The event is powered by
Sartorius BIA Separations
Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies.
The company’s Cornerstone® Biomanufacturing Development Services are the result of more than 20 years of hands-on experience with the most challenging biopharmaceutical products and offer a comprehensive approach of integrated process development solutions and novel technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products.
Sartorius BIA’s technology for manufacturing-scale purification is already used in the production of the first commercialized advanced therapeutics; the company also has a keen presence with novel drug candidates in the clinical pipeline.
NibaLabs
NibaLabs is a highly specialized analytical laboratory supporting the cell and gene therapy (CGT) industry through advanced multiplex dPCR assay development and a broad range of GMP-compliant analytical services.
With the launch of NibaPlex® – the world’s first all-in-one, ready-to-use multiplex dPCR assay for genome integrity quantification – NibaLabs has become a pivotal partner in CGT analytics.
We provide end-to-end analytical support from product development to commercial manufacturing, including site transfers, scale-up, process optimization, and batch-to-batch consistency.
Our analytical solutions ensure robust genome integrity monitoring, regulatory-compliant release specifications, and actionable insights that result in high-quality, safe, and efficacious CGT products.
Media partners
Gene Therapy Net
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
Drug Discovery & Development
Drug Discovery & Development (DDD), is dedicated to support the bio/pharma community to advance scientific innovations into active medical solutions. DDD discusses new insights in research, diagnosis and process to drive progress in drug discovery and drug development to help accelerate clinical milestones and success. DDD is a quarterly digital title, part of the Pharma Press portfolio and welcomes readers, partners and contributors to join its innovative and vibrant community to inspire and be inspired, evolve and progress. Please reach out to the team to find out more.